Ciprodex (Ciprofloxacin/Dexamethasone) Otic Suspension Dosing and Administration
Standard Dosage Regimen
For acute otitis externa in patients 6 months and older, instill 4 drops into the affected ear twice daily for 7 days. 1
- Each 4-drop dose delivers 0.14 mL of suspension containing 0.42 mg ciprofloxacin and 0.14 mg dexamethasone 1
- The medication is FDA-approved for otic use only—never for ophthalmic use or injection 1
- Shake the bottle well immediately before each use 1
Proper Administration Technique
Warm the bottle by holding it in your hand for 1-2 minutes before instillation to prevent dizziness from cold suspension. 1
Step-by-Step Instructions:
- Have the patient lie down with the affected ear facing upward 1, 2
- Instill the drops along the side of the ear canal until filled 2
- Maintain this position for 60 seconds (FDA label) or 3-5 minutes (AAO-HNS guidelines) to facilitate penetration 1, 2
- Perform tragal pumping: press the tragus (small cartilage flap in front of the ear) with gentle in-and-out movements several times after instillation 2
- Wipe away excess drops after rising 2
- Repeat for the opposite ear if needed 1
Having someone else administer the drops significantly improves adherence and proper delivery—only 40% of patients self-administer correctly during the first 3 days. 2
Clinical Context and Indications
Ciprodex is indicated specifically for acute otitis externa caused by Staphylococcus aureus and Pseudomonas aeruginosa. 1
- Also highly effective for acute otitis media with tympanostomy tubes (acute TTO), where it is superior to oral antibiotics 2, 3
- The 0.3% ciprofloxacin concentration (3000 mcg/mL) vastly exceeds the MIC of virtually all relevant pathogens 4
- Ciprodex is the only FDA-approved fluoroquinolone/steroid otic drop safe for use in both the external canal and middle ear 4, 5
Enhanced Delivery for Obstructed Canals
If the ear canal is obstructed by debris, edema, or discharge, perform aural toilet before administering drops to ensure medication reaches the infection site. 2
- Clean visible debris by blotting with cotton or gently suctioning with an infant nasal aspirator 2
- Remove dry crust with a cotton-tipped swab dipped in hydrogen peroxide or warm water 2
- If the canal remains severely edematous and obstructed, placement of a wick by the clinician may be necessary to facilitate drug delivery 2
- The wick may fall out spontaneously as inflammation resolves—this is a positive sign 2
Treatment Duration and Monitoring
Complete the full 7-day course even if symptoms improve earlier to prevent relapse. 1
- Discard any unused portion after completing therapy 1
- Patients should notify their physician if pain or symptoms fail to improve within 48-72 hours 6
- For acute TTO, clinical cure rates with topical therapy range from 77-96% versus only 30-67% with oral antibiotics 2
- Median time to cessation of otorrhea with Ciprodex is 4 days versus 7 days with oral amoxicillin/clavulanate 3
Comparative Efficacy
Ciprodex demonstrates superior clinical and microbiological outcomes compared to neomycin/polymyxin B/hydrocortisone (Cortisporin). 7, 8
- Clinical cure rates: 90.9% with Ciprodex versus 83.9% with Cortisporin at test-of-cure 7
- Microbiologic eradication: 94.7% versus 86.0% 7
- Pain relief occurs more rapidly with Ciprodex, with severe pain decreasing within the first 12 hours 8
- Ciprodex requires only twice-daily dosing versus three times daily for Cortisporin, improving adherence 7
Safety Considerations and Precautions
Keep the ear dry during treatment—avoid swimming, head dunking, and water entry into the ear canal. 2
- Cover the ear with cotton saturated with Vaseline during bathing or hair washing 2
- Do not use Ciprodex if there is a known hypersensitivity to quinolones or any component 1
- Contraindicated in viral infections (including herpes simplex) and fungal otic infections 1
- Limit treatment to a single 7-day course; prolonged or frequent use may induce fungal external otitis (otomycosis) 2, 5
Common Adverse Events:
- Ear discomfort (3%), ear pain (2.3%), ear pruritus (1.5%) 1
- Significantly fewer systemic side effects compared to oral antibiotics—no diarrhea (19.5% with oral amoxicillin/clavulanate), dermatitis, or GI upset 3
Critical Safety Advantage
Unlike aminoglycoside-containing drops (e.g., neomycin), Ciprodex is non-ototoxic and safe for use when tympanic membrane perforation or tympanostomy tubes are present. 2, 4, 5
- Aminoglycoside drops used for otitis externa can cause permanent hearing damage if they reach the middle ear 2
- Topical quinolones have no significant systemic absorption, making them safe in children despite systemic quinolone restrictions 2
When Systemic Antibiotics Are Needed
Reserve oral antibiotics for specific circumstances, not routine acute otitis externa or uncomplicated acute TTO. 2
Systemic therapy is appropriate when: